Programme Thesis
EWOR exists to back the world's most exceptional early-stage founders — including those at pre-idea — in building €1B+ category-defining tech companies. The programme was created because venture capital structurally fails 90% of founders; EWOR provides the mentorship (partners with €12B+ in combined company value: SumUp, Adjust, ProGlove, Felyx), network, and capital to close that gap. Selection is explicitly 99% on the person, not the idea, because EWOR's thesis is that outlier founders find the right idea — not the reverse.
Selection Criteria
• Outlier founder signal: one or more anomalous data points in background (CERN researcher, 16-year-old who sold to Yahoo, MIT nuclear scientist, world-ranked athlete, ex-Elon-Musk direct report, etc.) — reviewers are looking for something that makes them stop and reread
• €1B+ market ambition: the venture or the founder's domain must credibly point to unicorn-scale — EWOR backs the power-law game explicitly
• Obsession and resilience: willingness to commit 10+ years of extreme sacrifice, give up CEO control if needed, and handle hyperscaling stress — they publicly ask applicants to self-select out if this is not true
• 'Never followed a blueprint' archetype: non-linear, unconventional paths are favoured; founders who did things without institutional scaffolding score higher
• 99% on the person: idea can be missing entirely — 'Do I need a business idea? No' is stated explicitly in the FAQ
• Global scale vision: the problem must be of international significance, not local/regional
• VC-compatible mindset: must want to raise institutional capital and hyperscale — lifestyle founders are explicitly told not to apply
• Technical depth or rare domain mastery: the cohort is heavily populated with PhDs, researchers, and technical polymath profiles
• No geographic restriction: fellowship is global and virtual-first
• No incorporation required: startup entity can be formed within 18 months of acceptance
• Application is 15–20 minutes (short form); response promised within 3 weeks; rolling admissions
Past Winners / Cohort Profiles
Named fellows on the EWOR website reveal a consistent 'anomalous outlier' archetype across cohorts: Ariel Harmoko (UCL CS + 3x National Karting Champion + JP Morgan AI/ML intern → Artifact AI, €4M from a16z, €1M ARR within 12 months of fellowship); Faris Fakhry (MIT nuclear scientist, raised by Thiel Fellowship founders → Irradia Solutions, fusion-fission); Moises Barbera Ramos (built CERN's first dark matter detector + self-driving car algorithms → CLARO Surgical holographic surgery navigation, featured in Forbes); Erika Bondareva (Cambridge PhD biomedical AI, former CTO → Auryx, AI-powered preventative healthcare); Lukas Köstler (PhD 3D computer vision, direct report to Elon Musk → SE3 Labs next-gen 3D LLM); Jorgen Tveit (Oxford grad, Europe's largest-ever pre-seed by a first-time founder: €11M for Thaleron energy storage); Nick D'Aloisio (Oxford PhD, company founded at 16, €30M exit to Yahoo → neuro-inspired Deep Learning); Eric Steinberger (Cambridge dropout, ex-Meta/MIT researcher before age 20 → magic.dev, $700M+ raised); Dila Ekrem (TUM + MIT research + top-10 world-ranked fencer, 11 national titles, 35+ international medals → AI + startups); Gleb Babiy (co-authored and sold nutrition analysis tech at 17 → Aspect, PCOS metabolic health platform). Pattern: every fellow has one jaw-dropping anomaly — a world ranking, a precocious exit, a CERN credential, an Elon proximity — PLUS a plausible €1B+ company thesis. Industries: biotech/medtech, energy storage, AI, space, fintech, neuroscience.
Ideal Candidate Fingerprint
The platonic EWOR Ideation Fellow is a technically exceptional person with at least one extraordinary data point that cannot be explained by credential accumulation alone — something they did before anyone gave them permission or resources. They are building in a technically complex domain where their unique background creates a defensible moat, and they can articulate a €1B+ global market thesis in plain language. The idea can be embryonic, but the person must radiate the obsession and non-linear risk appetite of a founder who would build this regardless of a fellowship.
Recommended Framing
Eniola's strongest EWOR angle is the founder anomaly, not the technology. The application should open with the audacious data point — a Lagos-based pharmacist who taught herself ML in isolation, derived a drug-resistance predictor from first principles, and achieved 100% mutation coverage where every structure-limited competitor covers only 17.6% — without a lab, without institutional affiliation, without a co-founder. This maps directly onto EWOR's stated archetype: 'outliers who never followed a blueprint.' The €1B+ thesis is then presented as a natural consequence: a single protein-language-model primitive that attacks AMR, oncology, and antivirals simultaneously (EWOR's FAQ explicitly names 'AI for drug discovery' as a flagship fellow use case). The personal statement should resist the temptation to lead with the model — lead instead with the journey of a pharmacist who saw a structural failure in drug discovery (structure-dependency bottleneck) and resolved to fix it unilaterally, because that is the founder story EWOR funds.
Watch Out
• Acceptance rate is 0.1% from 35,000+ applicants — competition is extreme; the application's brevity (15–20 min form) means the personal statement and founder bio carry nearly all the weight and must be exceptional
• AUROC 0.634 is honest but modest — frame it as a validated proof-of-concept base (Ideation track explicitly does not require traction) rather than leading with the number; the 100% coverage statistic is the more compelling hook
• 3% equity tuition fee applies if EWOR invests (Ideation track) — Eniola should understand this before accepting; non-trivial for a solo founder
• EWOR explicitly warns applicants off if they are not prepared for VC-backed hyperscaling; Eniola's personal statement must make clear she is building a global company, not a research tool or consulting product
• No EU/French legal entity yet — acceptable per FAQ (18-month window post-acceptance), but Eniola should acknowledge the incorporation plan proactively
• Solo founder — explicitly permitted ('with or without a co-founder'), not a disqualifier
• No revenue traction — correct track (Ideation), not a red flag
• Africa geography — EWOR is virtual-first and explicitly global; no eligibility concern